Drug · DIN 02488671
TRANDOLAPRIL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since May 22, 2019.
- Drug Identification Number (DIN)
- 02488671
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Trandolapril C09AA10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRANDOLAPRIL | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 22, 2019: NOC 22181Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named TRANDOLAPRIL
- DIN 02488698 · Marketed
- DIN 02488701 · Marketed
- DIN 02488728 · Marketed
- DIN 02525046 · Marketed
- DIN 02525054 · Marketed
- DIN 02525070 · Marketed
- DIN 02526565 · Marketed
- DIN 02526573 · Marketed
- DIN 02526581 · Marketed
- DIN 02384507 · Cancelled Post Market
- DIN 02525038 · Approved